28 April 2026

Explore the Science Behind Established Methods

From immediate‑release tablets to novel dosage forms, USP Apparatus 1, 2, 5, and 6 continue to underpin dissolution science.­ Explore how SOTAX systems are applied in peer‑reviewed research – now available as a curated white paper or an online collection.

Dissolution testing remains a cornerstone of pharmaceutical research, linking formulation design, manufacturing, and in‑vitro performance. To support scientists seeking evidence‑based methodologies, we have compiled a new collection of peer‑reviewed scientific publications in which USP Apparatus 1, 2, 5, and 6 were used with SOTAX dissolution systems.

This curated body of work illustrates how classical dissolution apparatus continue to evolve alongside modern drug products – ranging from conventional oral solid dosage forms to modified‑release matrices.
 

Why SOTAX's USP 1, 2, 5 and 6 devices are used in research:
 

• Methodological continuity
  Widely accepted, pharmacopeial methods provide a strong foundation for reproducible, comparable dissolution data across studies and development phases.
   

• Application breadth
  From immediate‑release tablets to solid dispersions and modified release formulations, the apparatus covered address a wide spectrum of research questions.
   

• Precision and robustness
  SOTAX dissolution systems are frequently selected in research for their mechanical accuracy, hydrodynamic consistency, and suitability for method development and validation.
   

• Scientific visibility
  The cited publications demonstrate how data generated with SOTAX systems contribute to peer‑reviewed research and advance understanding of drug release behavior.

This new publication collection offers researchers a consolidated point of reference – whether you are developing new formulations, refining dissolution methodologies, or aligning in‑vitro tests with in‑vivo expectations.

Discover and download the white paper, or browse the online collection.